Log In
BCIQ
Print this Print this
 

Angiotensin II type 1 (AT1) receptor (AGTR1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Angiotensin II type 1 (AT1) receptor (AGTR1)

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 2 Marketed, 1 Marketed, 22 Approved, 1 Phase III, 1 Phase III, 2 Phase III, 3 Phase II, 1 Phase II, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IIPhase IIIApprovedMarketed
Cardiovascular

1

1

3

1

22

Endocrine / Metabolic

-

-

2

-

1

Neurology

-

-

1

-

2

Renal

-

1

-

-

1




 Products Targeting Angiotensin II type 1 (AT1) receptor (AGTR1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

0

0

$430.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today